Mark Helfand

发表

Appendix E. Studies Excluded at the Data Abstraction Phase by Topic and Reason

Jeanne-Marie Guise, Marian McDonagh, Peggy Nygren, 2003 .

[Table], Table of systematic reviews and studies cited, by key question

Michele Freeman, Mark Helfand, 2008 .

Figure 4, Foreign language literature flow diagram

Paul Gorman, Bruin Rugge, Howard Balshem, 2011 .

ORCAS: Network-Based Management of Cancer Clinical Trials

William R. Hersh, Elizabeth Brown, Mark Helfand, 1997, AMIA.

Patient Narratives Representing Patient Voices to Inform Research: A Pilot Qualitative Study

Joan S. Ash, Erika Cottrell, Mark Helfand, 2015, ITCH.

Figure 2, [Sequential Evaluation Scheme for Each Risk Factor].

Rongwei Fu, Miranda Walker, Kevin Rogers, 2009 .

Clinical outcomes resulting from telemedicine interventions: a systematic review

James Wallace, William R. Hersh, Dale Kraemer, 2001, BMC Medical Informatics Decis. Mak..

Incorporating considerations of resources use into grading recommendations

Gordon H Guyatt, Andrew D Oxman, Holger J Schünemann, 2008, BMJ : British Medical Journal.

GRADE guidelines: 22. The GRADE approach for tests and strategies-from test accuracy to patient-important outcomes and recommendations.

Mohammad Hassan Murad, Gordon H Guyatt, Lotty Hooft, 2019, Journal of clinical epidemiology.

Figure 1, Analytic framework for a new enteral supplement to heal bedsores

Howard Balshem, Mark Helfand, 2009 .

GRADE guidelines: 3. Rating the quality of evidence.

Howard Balshem, Gordon H Guyatt, Jan Brozek, 2011, Journal of clinical epidemiology.

Incorporating Information About Cost-Effectiveness Into Evidence-Based Decision-Making: The Evidence-Based Practice Center (EPC) Model

Mark Helfand, M. Helfand, 2005, Medical care.

Methods for the Drug Effectiveness Review Project

Daniel E Jonas, Gerald Gartlehner, Mark Helfand, 2012, BMC Medical Research Methodology.

For Personal Use. Mass Reproduce Only with Permission from Mayo Clinic Proceedings. for Personal Use. Mass Reproduce Only with Permission from Mayo Clinic Proceedings. Homocysteine Level and Coronary Heart Disease Incidence: a Systematic Review and Meta-analysis

Rongwei Fu, Kevin Rogers, Michele Freeman, 2022 .

Technology Assessment: Early Sense for Monitoring Vital Signs in Hospitalized Patients

Vivian Christensen, Mark Helfand, M. Helfand, 2016 .

Comparative efficacy and safety of long-acting oral opioids for chronic non-cancer pain: a systematic review.

Roger Chou, Mark Helfand, R. Chou, 2003, Journal of pain and symptom management.

Ten Years of Longitudinal Research on U.S. Adolescent Sexual Behavior: Developmental Correlates of Sexual Intercourse, and the Importance of Age, Gender and Ethnic Background.

Mark Helfand, Melanie J. Zimmer-Gembeck, M. Helfand, 2008 .

Shared Decision Making, Decision Aids, and Risk Communication

Mark Helfand, 2007, Medical decision making : an international journal of the Society for Medical Decision Making.

Screening for Postmenopausal Osteoporosis: A Review of the Evidence for the U.S. Preventive Services Task Force

Mark Helfand, S. Woolf, M. Helfand, 2002, Annals of Internal Medicine.

CARE guidelines for case reports: explanation and elaboration document.

David Moher, Douglas G Altman, Larissa Shamseer, 2017, Journal of clinical epidemiology.

Reporting Discrepancies Between the ClinicalTrials.gov Results Database and Peer-Reviewed Publications

Jeanne-Marie Guise, Robin Paynter, Marian McDonagh, 2014, Annals of Internal Medicine.

C-Reactive Protein as a Risk Factor for Coronary Heart Disease: A Systematic Review and Meta-analyses for the U.S. Preventive Services Task Force

Rongwei Fu, David I Buckley, Kevin Rogers, 2009, Annals of Internal Medicine.

AHRQ series paper 3: identifying, selecting, and refining topics for comparative effectiveness systematic reviews: AHRQ and the effective health-care program.

Evelyn P Whitlock, Mark Helfand, Michelle Eder, 2010, Journal of clinical epidemiology.

Comparative efficacy and safety of skeletal muscle relaxants for spasticity and musculoskeletal conditions: a systematic review.

Roger Chou, Mark Helfand, Kim Peterson, 2004, Journal of pain and symptom management.

Grading the Strength of a Body of Evidence When Comparing Medical Interventions

Douglas K Owens, David Atkins, Jonathan Treadwell, 2009 .

GRADE guidelines: 7. Rating the quality of evidence--inconsistency.

Gordon H Guyatt, Elie A Akl, James Woodcock, 2011, Journal of clinical epidemiology.

GRADE guidelines: 12. Preparing summary of findings tables-binary outcomes.

Gordon H Guyatt, Jason W Busse, Robin Christensen, 2013, Journal of clinical epidemiology.

Emerging Risk Factors for Coronary Heart Disease: A Summary of Systematic Reviews Conducted for the U.S. Preventive Services Task Force

Rongwei Fu, David I Buckley, Kevin Rogers, 2009, Annals of Internal Medicine.

AHRQ series paper 5: grading the strength of a body of evidence when comparing medical interventions--agency for healthcare research and quality and the effective health-care program.

Douglas K Owens, Kathleen N Lohr, David Atkins, 2010, Journal of clinical epidemiology.

Using evidence reports: progress and challenges in evidence-based decision making.

Mark Helfand, M. Helfand, 2005, Health affairs.

Methodological standards and patient-centeredness in comparative effectiveness research: the PCORI perspective.

John P. A. Ioannidis, Steven N. Goodman, David R. Flum, 2012, JAMA.

A CTSA Agenda to Advance Methods for Comparative Effectiveness Research

Anirban Basu, Mark Helfand, Sean Tunis, 2011, Clinical and translational science.

Telemedicine for the Medicare Population: Summary

William R. Hersh, Dale F. Kraemer, Mark Helfand, 2001 .

Screening for Lipid Disorders in Adults: Selective Update of 2001 US Preventive Services Task Force Review

Mark Helfand, Susan Carson, 2008 .

Periodontal Disease and Coronary Heart Disease Incidence: A Systematic Review and Meta-analysis

Rongwei Fu, Michele Freeman, Mark Helfand, 2008, Journal of General Internal Medicine.

A systematic review of the efficacy of telemedicine for making diagnostic and management decisions

Dale Kraemer, William Hersh, Mark Helfand, 2002, Journal of telemedicine and telecare.

Effectiveness and Harms of Recombinant Human Bone Morphogenetic Protein-2 in Spine Fusion

Arpita Tiwari, Marian McDonagh, Shelley Selph, 2013, Annals of Internal Medicine.

AHRQ series paper 2: principles for developing guidance: AHRQ and the effective health-care program.

Howard Balshem, Mark Helfand, M. Helfand, 2010, Journal of clinical epidemiology.

Screening for Developmental Dysplasia of the Hip: A Systematic Literature Review for the US Preventive Services Task Force

Barbara P. Yawn, Mark Helfand, B. Yawn, 2006, Pediatrics.

Current methods of the U.S. Preventive Services Task Force

David Atkins, Kathleen N. Lohr, Steven H. Woolf, 2001 .

Challenges in the development and reimbursement of personalized medicine-payer and manufacturer perspectives and implications for health economics and outcomes research: a report of the ISPOR personalized medicine special interest group.

Katherine Payne, David Veenstra, Uwe Siebert, 2012, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.